Successful EGFR-TKI Rechallenge of Leptomeningeal Carcinomatosis after Gefitinib-induced Interstitial Lung Disease

Author： Nakamichi Shinji Kubota Kaoru Horinouchi Hidehito Kanda Shintaro Fujiwara Yutaka Nokihara Hiroshi Yamamoto Noboru Tamura Tomohide

Publisher： Oxford University Press

ISSN： 1465-3621

Source： Japanese Journal of Clinical Oncology, Vol.43, Iss.4, 2013-04, pp. : 422-425

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gefitinib-induced interstitial lung disease-addition of intravenous cyclophosphamide to corticosteroids is a valuable treatment option: A case report

By Goto Yasushi Hojo Masayuki Takeda Yuichiro Kobayashi Nobuyuki Kudo Koichiro

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 753-755

Humana Press, Inc

Access to resources Recommend Favorite

Successful treatment of gefitinib-induced acute interstitial pneumonitis with high-dose corticosteroid: a case report and literature review

By Kuo Li-Chiao

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 79-82

Humana Press, Inc

Access to resources Recommend Favorite

Acute gefitinib-induced pneumonitis

By Ohyanagi Fumiyoshi Ando Yuichi Nagashima Fumio Narabayashi Masaru Sasaki Yasutsuna

International Journal of Clinical Oncology, Vol. 9, Iss. 5, 2004-10 ,pp. : 406-409

Springer Publishing Company

Access to resources Recommend Favorite

Successful treatment of EGFR-mutated non-small cell lung cancer with reduced-dose gefitinib: A case report

Experimental and Therapeutic Medicine, Vol. 10, Iss. 1, 2015-01 ,pp. : 386-388

Spandidos Publications

Access to resources Recommend Favorite

Gefitinib in combination with prednisolone to avoid interstitial lung disease during non-small cell lung cancer treatment: A case report

Oncology Letters, Vol. 5, Iss. 5, 2013-01 ,pp. : 1599-1600

Spandidos Publications

Access to resources Recommend Favorite